S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
All the trading advice you’ve ever received boils down to this (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
All the trading advice you’ve ever received boils down to this (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
All the trading advice you’ve ever received boils down to this (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
All the trading advice you’ve ever received boils down to this (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way

Terumo (TRUMY) Stock Price, News & Analysis

$32.71
-0.37 (-1.12%)
(As of 12/8/2023 ET)
Compare
Today's Range
$32.48
$32.94
50-Day Range
$25.15
$32.71
52-Week Range
$25.11
$33.66
Volume
25,374 shs
Average Volume
31,184 shs
Market Capitalization
$24.46 billion
P/E Ratio
37.60
Dividend Yield
0.67%
Price Target
N/A

TRUMY stock logo

About Terumo Stock (OTCMKTS:TRUMY)

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

TRUMY Stock Price History

TRUMY Stock News Headlines

Terumo Co. (OTCMKTS:TRUMY) Short Interest Down 27.4% in November
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Lakewood Company Putting People at Risk?
Ivanka Trump
Trump Reinstated To Facebook And Instagram
OMG. Trump Has Started Texting.
Bank of Japan Doves Propel Tokyo Shares Up
See More Headlines
Receive TRUMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/10/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Medical & hospital equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TRUMY
Previous Symbol
NASDAQ:TRUMY
Employees
30,207
Year Founded
1964

Profitability

Net Income
$661.01 million
Pretax Margin
14.16%

Debt

Sales & Book Value

Annual Sales
$6.07 billion
Cash Flow
$1.58 per share
Book Value
$11.00 per share

Miscellaneous

Free Float
N/A
Market Cap
$24.46 billion
Optionable
Not Optionable
Beta
0.58

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Shinjiro Sato (Age 63)
    President, CEO, Group Managing Executive Officer & Director
    Comp: $835.54k
  • Mr. Naoki Muto
    Chief Accounting & Financial Officer and Group Executive Officer
  • Itaru Sakaguchi
    Senior Executive Officer & COO
  • Fumihisa Hirose
    Group Managing Executive Officer, GM of Strategic Planning Department & CTO
  • Mr. Shoji Hatano (Age 64)
    Group Senior Mng. Exe. Off. of Corporate Affairs Dept., Legal and Compliance Dept. & Director
  • Ms. Miho Mizuguchi
    Executive Officer, Chief Legal Officer and GM of CLO Office, Legal & Compliance Department
  • Tomoko Adachi
    Chief Human Resources Officer & Group Executive Officer
  • James Rushworth
    Group Executive Officer & Chief Commercial Officer
  • Mr. Hikaru Samejima
    Group Senior Managing Executive Officer
  • Mr. Kazunori Hirose (Age 59)
    Group Managing Executive Officer, Chief Manufacturing Officer & Director

Should I Buy Terumo Stock? TRUMY Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Terumo was last updated on Tuesday, November 28, 2023 at 10:07 PM.

Pros

Here are some ways that investors could benefit from investing in Terumo Co.:

  • Terumo Corporation is a leading manufacturer and seller of medical products and equipment globally, which indicates a strong market presence and potential for growth.
  • The company operates in multiple segments, including Cardiac and Vascular, Medical Care Solutions, and Blood and Cell Technologies, providing diversification and opportunities for revenue generation.
  • Terumo Corporation offers a wide range of medical products and equipment, including angiographic guidewires, catheters, stents, ultrasound systems, and blood processing systems, which cater to various healthcare needs and have the potential for high demand.
  • The company has a history dating back to 1921 and has established itself as a trusted brand in the medical and hospital equipment industry.
  • Recent developments, although not specified in the provided context, could include advancements in medical technology, product innovation, strategic partnerships, or expansion into new markets, which can contribute to the company's growth and investor returns.

Cons

Investors should be bearish about investing in Terumo Co. for these reasons:

  • Like any investment in the medical industry, Terumo Co. is subject to regulatory risks, including changes in healthcare policies, product approvals, and reimbursement rates, which can impact the company's financial performance.
  • Competition in the medical and hospital equipment industry is intense, with numerous global and local players vying for market share. Terumo Co. may face challenges in maintaining its competitive edge and market position.
  • Fluctuations in currency exchange rates, especially for a company with international operations like Terumo Co., can impact its financial results and investor returns.
  • The current stock price of Terumo Co. is not provided in the given context, making it difficult to assess its attractiveness from a valuation perspective. Investors should consider the stock price in relation to the company's financial performance and industry trends.
  • Investors should conduct thorough research and analysis, considering factors such as the company's financial health, growth prospects, competitive landscape, and industry trends, before making investment decisions.














TRUMY Stock Analysis - Frequently Asked Questions

Should I buy or sell Terumo stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Terumo in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TRUMY shares.
View TRUMY analyst ratings
or view top-rated stocks.

How have TRUMY shares performed in 2023?

Terumo's stock was trading at $28.1850 at the beginning of 2023. Since then, TRUMY stock has increased by 16.1% and is now trading at $32.71.
View the best growth stocks for 2023 here
.

Are investors shorting Terumo?

Terumo saw a decline in short interest in November. As of November 15th, there was short interest totaling 5,300 shares, a decline of 27.4% from the October 31st total of 7,300 shares. Based on an average daily trading volume, of 94,100 shares, the short-interest ratio is currently 0.1 days.
View Terumo's Short Interest
.

Is Terumo a good dividend stock?

Terumo (OTCMKTS:TRUMY) pays an annual dividend of $0.22 per share and currently has a dividend yield of 0.66%. The dividend payout ratio is 25.29%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TRUMY will have a dividend payout ratio of 19.47% next year. This indicates that the company will be able to sustain or increase its dividend.

How do I buy shares of Terumo?

Shares of TRUMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:TRUMY) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -